Apoptosis in atherosclerosis: focus on oxidized lipids and inflammation

被引:107
作者
Martinet, W
Kockx, MM
机构
[1] CATRIMA, Antwerp, Belgium
[2] Univ Antwerp, Div Pharmacol, Wilrijk, Belgium
关键词
D O I
10.1097/00041433-200110000-00009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
An increasing body of evidence from both animal models and human specimens suggests that apoptosis or programmed cell death is a major event in the pathophysiology of atherosclerosis. Although the significance of apoptosis in atherosclerosis remains unclear, it has been proposed that apoptotic cell death contributes to plaque instability, rupture and thrombus formation. Biochemical and genetic analyses of apoptosis provide an increasingly detailed picture of the intracellular signaling pathways involved. Nevertheless, it remains to be determined whether apoptosis can become a clinically important approach to modulate plaque progression. In this review, we have outlined some of the most recent results concerning apoptosis in atherosclerosis with a special focus on oxidized lipids, inflammation and therapeutic regulation of the apoptotic cell death process. Curr Opin Lipidol 12:535-541., (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 68 条
[1]
Aikawa M, 2001, CIRCULATION, V103, P276
[2]
Aikawa M, 2000, ANN NY ACAD SCI, V902, P140
[3]
The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7 [J].
Behrensdorf, HA ;
van de Craen, M ;
Knies, UE ;
Vandenabeele, P ;
Clauss, M .
FEBS LETTERS, 2000, 466 (01) :143-147
[4]
Sensitivity to Fas-mediated apoptosis is determined below receptor level in human vascular smooth muscle cells [J].
Chan, SW ;
Hegyi, L ;
Scott, S ;
Cary, NRB ;
Weissberg, PL ;
Bennett, MR .
CIRCULATION RESEARCH, 2000, 86 (10) :1038-1046
[5]
Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages:: Evidence that oxidation-specific epitopes mediate macrophage recognition [J].
Chang, MK ;
Bergmark, C ;
Laurila, A ;
Hörkkö, S ;
Han, KH ;
Friedman, P ;
Dennis, EA ;
Witztum, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (11) :6353-6358
[6]
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques - Implications for plaque stabilization [J].
Crisby, M ;
Nordin-Fredriksson, G ;
Shah, PK ;
Yano, J ;
Zhu, J ;
Nilsson, J .
CIRCULATION, 2001, 103 (07) :926-933
[7]
Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques [J].
Cromheeke, KM ;
Kockx, MM ;
De Meyer, GRY ;
Bosmans, JM ;
Bult, H ;
Beelaerts, WJF ;
Vrints, CJ ;
Herman, AG .
CARDIOVASCULAR RESEARCH, 1999, 43 (03) :744-754
[8]
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation [J].
Daemen, MARC ;
van't Veer, C ;
Denecker, G ;
Heemskerk, VH ;
Wolfs, TGAM ;
Clauss, M ;
Vandenabeele, P ;
Buurman, WA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (05) :541-549
[9]
De Meyer G. R., 2000, Journal of Submicroscopic Cytology and Pathology, V32, P458
[10]
Expression of inducible nitric oxide synthase and Fas/Fas ligand correlates with the incidence of apoptotic cell death in atheromatous plaques of human coronary arteries [J].
Esaki, T ;
Hayashi, T ;
Muto, E ;
Kano, H ;
Kumar, TN ;
Asai, Y ;
Sumi, D ;
Iguchi, A .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2000, 4 (06) :561-571